Efficacy and effectiveness of tumour necrosis factor inhibitors in the treatment of rheumatoid arthritis in randomized controlled trials and routine clinical practice-Reference-Cited by-同舟云学术

Efficacy and effectiveness of tumour necrosis factor inhibitors in the treatment of rheumatoid arthritis in randomized controlled trials and routine clinical practice

Published:2017-01-07 Issue: Volume: Page:kew467
ISSN:1462-0324
Container-title:Rheumatology
language:en
Short-container-title:Rheumatology

Author:

Aaltonen Kalle J.,Ylikylä Suvi,Tuulikki Joensuu Jaana,Isomäki Pia,Pirilä Laura,Kauppi Markku,Rannio Tuomas,Eklund Kari,Blom Marja,Nordström Dan

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Reference40 articles.

1. Rheumatoid Arthritis (online). Current Care Guidelines. Working group set up by the Finnish Medical Society Duodecim and the Finnish Society for Rheumatology. [Internet]. 2015 [cited 2015 18]. http://www.kaypahoito.fi/web/kh/suositukset/suositus?id=hoi21010 (18 October 2015, date last accessed).

2. Systematic review and meta-analysis of the efficacy and safety of existing TNF blocking agents in treatment of rheumatoid arthritis;Aaltonen;PLoS One,2012

3. Effectiveness of tumor necrosis factor inhibitors in rheumatoid arthritis in an observational cohort study: Comparison of patients according to their eligibility for major randomized clinical trials

4. Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis

5. Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PERFECTRA: a pragmatic, multicentre, real-life study comparing treat-to-target strategies with baricitinib versus TNF inhibitors in patients with active rheumatoid arthritis after failure on csDMARDs;RMD Open;2024-05

2. Real-World Use and Effectiveness Outcomes in Patients with Rheumatoid Arthritis Treated with Upadacitinib: An Analysis from the CorEvitas Registry;Rheumatology and Therapy;2024-02-12

3. Predicting anti-TNF treatment response in rheumatoid arthritis: An artificial intelligence-driven model using cytokine profile and routine clinical practice parameters;Heliyon;2024-01

4. Remission, response, retention and persistence to treatment with disease-modifying agents in patients with rheumatoid arthritis: a study of harmonised Swedish, Danish and Norwegian cohorts;RMD Open;2023-09

5. Real-World Sarilumab Use and Rule Testing to Predict Treatment Response in Patients with Rheumatoid Arthritis: Findings from the RISE Registry;Rheumatology and Therapy;2023-06-22